Ibrutinib (PCI-32765)；依鲁替尼；936563-96-1

Formula:C25H24N6O2

Molecular Weight：440.51

Appearance：White powder

Purity：98+%

Ibrutinib, also known as PCI-32765, is a potent and orally active BTK inhibitor. Ibrutinib binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK.